[ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. II. DRUG-THERAPEUTIC INQUIRY ON CEREBROVASCULAR SIDE-EFFECTS, WITH MEDICOLEGAL ASPECTS OF THE USE OF MAO INHIBITORS].
D000293:Adolescent; D000928:Antidepressive Agents; D001919:Bradycardia; D002561:Cerebrovascular Disorders; D003863:Depression; D003866:Depressive Disorder; D004357:Drug Synergism; D004358:Drug Therapy; D005853:Geriatrics; D006973:Hypertension; D007603:Jurisprudence; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D013610:Tachycardia; D014116:Toxicology
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D008995:Monoamine Oxidase
ADOLESCENCE; ANTIDEPRESSIVE AGENTS; BRADYCARDIA; CEREBROVASCULAR DISORDERS; DEPRESSION; DRUG SYNERGISM; DRUG THERAPY; GERIATRICS; HYPERTENSION; JURISPRUDENCE; MONOAMINE OXIDASE INHIBITORS; TACHYCARDIA; TOXICOLOGIC REPORT
ANTIDEPRESSIV BEHANDLING MED MONOAMINOXIDAS-(MAO)-HAEMMARE. II. MEDICINALSTYRELSENS ENKAET OM CEREBROVASKULAERA BIVERKNINGAR SAMT MEDIKOLEGALA SYNPUNKTER PA ANVAENDNINGEN AV MAO-HAEMMARE.